Suppr超能文献

关于内源性腺苷在青蛙神经肌肉接头处的作用、失活及来源

On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction.

作者信息

Ribeiro J A, Sebastião A M

机构信息

Laboratory of Pharmacology, Gulbenkian Institute of Science, Oeiras, Portugal.

出版信息

J Physiol. 1987 Mar;384:571-85. doi: 10.1113/jphysiol.1987.sp016470.

Abstract
  1. The effects of adenosine deaminase, inosine, alkylxanthines (8-phenyltheophylline (8-PT), theophylline and isobutylmethylxanthine (IBMX], dipyridamole, alpha, beta-methylene ADP (AOPCP) and ATP analogues (alpha, beta-methylene ATP and beta, gamma-methylene ATP) on evoked end-plate potentials (e.p.p.s) were investigated in innervated sartorius muscles of the frog, in which twitches had been prevented with tubocurarine. The effects of 8-PT and IBMX on the amplitude and quantal content of e.p.p.s were also investigated in innervated sartorius muscles of the frog, in which twitches had been prevented with high-magnesium solutions. 2. Adenosine deaminase reversibly increased the amplitude of e.p.p.s and prevented the reduction caused by exogenously applied adenosine on e.p.p. amplitude. The increase caused by adenosine deaminase was equivalent to the decrease caused by 12 +/- 5.8 microM-adenosine on e.p.p. amplitude. 3. Inosine, the product of adenosine deamination, was virtually devoid of effect on e.p.p.s. 4. The adenosine receptor antagonists at the frog neuromuscular junction, 8-PT and theophylline, increased in a concentration-dependent manner the amplitude of e.p.p.s in the presence of tubocurarine. 8-PT increased the amplitude and quantal content of e.p.p.s in the presence of high magnesium. IBMX, which does not behave as an adenosine receptor antagonist at the frog neuromuscular junction, decreased the amplitude of e.p.p.s in the presence of tubocurarine or high-magnesium solutions. 5. Dipyridamole, an adenosine uptake blocker, decreased the amplitude of e.p.p.s, and in a concentration that did not affect neuromuscular transmission potentiated the depressing effect of adenosine, but not that of 2-chloroadenosine, on the amplitude of e.p.p.s. 6. AOPCP, an inhibitor of 5'-nucleotidase, increased the amplitude of e.p.p.s and markedly attenuated the depressing effect of ATP, but not that of adenosine, on e.p.p. amplitude. 7. The ATP analogue, alpha, beta-methylene ATP, which is not a substrate for 5'-nucleotidase, was virtually devoid of effect on e.p.p.s. beta, gamma-Methylene ATP, which can be a substrate for 5'-nucleotidase, mimicked the depressing effect of ATP on e.p.p. amplitude, an effect which was also reduced by AOPCP. 8. It is concluded that in conditions in which the initial quantal content is assumed to be normal (1) endogenous adenosine depresses neuromuscular transmission, (2) at the neuromuscular junction adenosine is inactivated through a dipyridamole-sensitive uptake process, and (3) released adenine nucleotides might contribute to the pool of endogenous adenosine which modulates neuromuscular transmission.
摘要
  1. 在已用筒箭毒碱抑制肌肉抽搐的青蛙受神经支配的缝匠肌中,研究了腺苷脱氨酶、肌苷、烷基黄嘌呤(8-苯基茶碱(8-PT)、茶碱和异丁基甲基黄嘌呤(IBMX))、双嘧达莫、α,β-亚甲基二磷酸腺苷(AOPCP)以及ATP类似物(α,β-亚甲基ATP和β,γ-亚甲基ATP)对诱发终板电位(e.p.p.s)的影响。在已用高镁溶液抑制肌肉抽搐的青蛙受神经支配的缝匠肌中,还研究了8-PT和IBMX对e.p.p.s幅度和量子含量的影响。2. 腺苷脱氨酶可逆性增加e.p.p.s的幅度,并阻止外源性腺苷引起的e.p.p.幅度降低。腺苷脱氨酶引起的增加相当于12±5.8微摩尔/升腺苷引起的e.p.p.幅度降低。3. 腺苷脱氨产物肌苷对e.p.p.s几乎没有影响。4. 青蛙神经肌肉接头处的腺苷受体拮抗剂8-PT和茶碱,在存在筒箭毒碱的情况下,以浓度依赖方式增加e.p.p.s的幅度。在高镁存在下,8-PT增加e.p.p.s的幅度和量子含量。在青蛙神经肌肉接头处不作为腺苷受体拮抗剂的IBMX,在存在筒箭毒碱或高镁溶液时降低e.p.p.s的幅度。5. 腺苷摄取阻滞剂双嘧达莫降低e.p.p.s的幅度,并且在不影响神经肌肉传递的浓度下,增强腺苷对e.p.p.s幅度的抑制作用,但不增强2-氯腺苷的抑制作用。6. 5'-核苷酸酶抑制剂AOPCP增加e.p.p.s的幅度,并显著减弱ATP对e.p.p.幅度的抑制作用,但不减弱腺苷的抑制作用。7. 不是5'-核苷酸酶底物的ATP类似物α,β-亚甲基ATP对e.p.p.s几乎没有影响。可以作为5'-核苷酸酶底物的β,γ-亚甲基ATP模拟了ATP对e.p.p.幅度的抑制作用,AOPCP也降低了这种作用。8. 得出结论,在假定初始量子含量正常的情况下:(1)内源性腺苷抑制神经肌肉传递;(2)在神经肌肉接头处,腺苷通过双嘧达莫敏感的摄取过程失活;(3)释放的腺嘌呤核苷酸可能有助于调节神经肌肉传递的内源性腺苷池。

相似文献

引用本文的文献

3
Purinergic Tuning of the Tripartite Neuromuscular Synapse.嘌呤能调节三突触神经肌肉接点
Mol Neurobiol. 2023 Jul;60(7):4084-4104. doi: 10.1007/s12035-023-03317-8. Epub 2023 Apr 5.
7
Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors.肌萎缩侧索硬化症(ALS)与腺苷受体
Front Pharmacol. 2018 Apr 16;9:267. doi: 10.3389/fphar.2018.00267. eCollection 2018.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验